LLY

795.51

-2.92%↓

JNJ

153.76

-0.81%↓

ABBV

187.73

-1.55%↓

NVO

74.91

-2.51%↓

UNH

307.38

+0.62%↑

LLY

795.51

-2.92%↓

JNJ

153.76

-0.81%↓

ABBV

187.73

-1.55%↓

NVO

74.91

-2.51%↓

UNH

307.38

+0.62%↑

LLY

795.51

-2.92%↓

JNJ

153.76

-0.81%↓

ABBV

187.73

-1.55%↓

NVO

74.91

-2.51%↓

UNH

307.38

+0.62%↑

LLY

795.51

-2.92%↓

JNJ

153.76

-0.81%↓

ABBV

187.73

-1.55%↓

NVO

74.91

-2.51%↓

UNH

307.38

+0.62%↑

LLY

795.51

-2.92%↓

JNJ

153.76

-0.81%↓

ABBV

187.73

-1.55%↓

NVO

74.91

-2.51%↓

UNH

307.38

+0.62%↑

Search

Emergent BioSolutions Inc

Cerrado

SectorSalud

6.26

Resumen

Variación precio

24h

Actual

Mínimo

6.15

Máximo

6.4

Métricas clave

By Trading Economics

Ingresos

99M

68M

Ventas

33M

222M

BPA

0.71

Margen de beneficio

30.603

Empleados

900

EBITDA

120M

133M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+116% upside

Dividendos

By Dow Jones

Próximas Ganancias

5 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

43M

360M

Apertura anterior

6.26

Cierre anterior

6.26

Noticias sobre sentimiento de mercado

By Acuity

34%

66%

99 / 381 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Emergent BioSolutions Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

16 jun 2025, 22:33 UTC

Adquisiciones, fusiones, absorciones

KKR to Acquire Australian Power Provider Zenith Energy

16 jun 2025, 21:55 UTC

Principales Movimientos del Mercado

Geospace Technologies Shares Up on Petrobras Pact

16 jun 2025, 17:04 UTC

Principales Movimientos del Mercado

Roku Shares Climb on Advertising Deal with Amazon

16 jun 2025, 23:51 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

16 jun 2025, 23:51 UTC

Charlas de Mercado

Nikkei May Trade Range Bound Amid Israel-Iran Conflict -- Market Talk

16 jun 2025, 23:41 UTC

Charlas de Mercado

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

16 jun 2025, 23:10 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

XRG Has 'Viable Path' to Approval of Santos Takeover -- Market Talk

16 jun 2025, 23:02 UTC

Charlas de Mercado

Auckland Airport Unlikely to Hit Target for International Passengers -- Market Talk

16 jun 2025, 22:32 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Santos Unlikely to Attract Rival Bidder to XRG -- Market Talk

16 jun 2025, 22:03 UTC

Adquisiciones, fusiones, absorciones

KKR & Co. to Buy Zenith Energy From Consortium Including Pacific Equity Partners, OPSEU Pension Trust, Foresight Group >KKR

16 jun 2025, 22:00 UTC

Adquisiciones, fusiones, absorciones

KKR Acquires Leading Australian Independent Power Producer Zenith Energy >KKR

16 jun 2025, 21:56 UTC

Ganancias

Lennar Has an Earnings Miss. The Stock Slips. -- Barrons.com

16 jun 2025, 21:10 UTC

Adquisiciones, fusiones, absorciones

Mitsubishi in Talks to Sign $8 Billion Deal With Gas Producer Aethon -- WSJ

16 jun 2025, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

16 jun 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

16 jun 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

16 jun 2025, 20:49 UTC

Charlas de Mercado

Fitch Revises Canadian Provinces Fiscal Outlook to 'Deteriorating' -- Market Talk

16 jun 2025, 20:14 UTC

Adquisiciones, fusiones, absorciones

Update: EchoStar Stock Surges. It's Short Covering and President Trump. -- Barrons.com

16 jun 2025, 20:13 UTC

Charlas de Mercado

Natural Gas Gains on Warmer Outlook -- Market Talk

16 jun 2025, 19:58 UTC

Adquisiciones, fusiones, absorciones

OpenAI and Microsoft Tensions Are Reaching a Boiling Point -- WSJ

16 jun 2025, 19:13 UTC

Charlas de Mercado

Middle-East Conflict May Not Push Up Oil Long Term -- Market Talk

16 jun 2025, 19:09 UTC

Charlas de Mercado

Amazon-Roku Deal Shows Competition for Streaming Ad Space -- Market Talk

16 jun 2025, 18:43 UTC

Charlas de Mercado

May Could Mark Nascent Recovery in Canada Housing Market -- Market Talk

16 jun 2025, 18:36 UTC

Charlas de Mercado

Soybeans May Get Boost from Renewable Fuel Obligations -- Market Talk

16 jun 2025, 18:29 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

16 jun 2025, 18:29 UTC

Charlas de Mercado

Shopify Appears More Resilient Than Feared -- Market Talk

16 jun 2025, 18:22 UTC

Charlas de Mercado

Citi Forecasts Downturn in Gold Futures -- Market Talk

16 jun 2025, 16:42 UTC

Charlas de Mercado

Homebuyers' Downpayments Are Shrinking For First Time in 2 Years -- Market Talk

16 jun 2025, 16:37 UTC

Charlas de Mercado

Big, Beautiful Bill Might Not Mean Big Growth -- Market Talk

16 jun 2025, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Emergent BioSolutions Inc Esperado

Precio Objetivo

By TipRanks

116% repunte

Estimación a 12 meses

Media 13.5 USD  116%

Máximo 15 USD

Mínimo 12 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Emergent BioSolutions Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

2

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

4.95 / N/ASoporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

99 / 381 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Emergent BioSolutions Inc

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It also provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; BAT for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Reactive Skin Decontamination Lotion Kit to remove or neutralize chemical warfare agents from the skin; Trobigard, a atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing CGRD-001 for the treatment of poisoning by organophosphorus nerve agents or organophosphorus compounds; EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; SIAN Antidote for initial treatment of certain or suspected acute cyanide poisoning; UniFlu for immunity against influenza A and B viruses; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.